Not exact matches
Foundr Version 1.0 features 7 comprehensive chapters covering everything from starting a business, building a team, raising
capital and more from over 30 game - changing entrepreneurs — we're not talking a simple collection of mumbo - jumbo interviews where you dig for useful
little nuggets of gold: we've broken it down to deliver the stuff you
actually need to know immediately.
Now it's
actually possible for companies on the per share basis, maybe not on the aggregate basis, but on the per share basis, to grow a
little bit faster because they retain more of their earnings and they will find ways to reinvest
capital internally.
Remmember that it's best to explicitly define what the fundraising milestone strategy is during the seed stage Once a startup has raised seed
capital, plenty of theories and advice exist on how to successfully raise a Series A. Recently, we looked at our own portfolio at NextView Ventures to dig a
little deeper on how startups
actually raise that next round of financing.
It is not surprising then that after an exhaustive study of the impact of the green revolution in five countries, Keith Griffin concluded that the transfer of
capital - intensive, market - oriented technology not only had
little positive effect on malnutrition, but
actually increased the range of inequality, wiped out many subsistence farmers (usually women in most of the poorer countries), and plunged them further into destitution.
Although tempting to use the results to conclude that management should pay dividends instead of reinvesting, or that growth stocks are poor investments, or that
capital - intensive businesses are bad investments, etc, better to be clear exactly how
little is
actually proved.
Actually, they did comment a
little on cashflow: «Working
capital had a negative impact on cash flow in the period reflecting the Group's continuing focus on driving revenue growth….Net
capital expenditure... also reflects the Group's commitment to fund growth.
And, very locally: I let my IT flag fly a
little bit while responding to a
Capital Rants post about physical headquarters versus virtual operations, a question biotech and pharma companies
actually deal with a lot, given the incredible range of service providers to the industry; and I went to a planning meeting for Ontario's presence at BIO2009 in Atlanta (hint: cool pavilion, free coffee).
«The new guidance
actually has
little impact — it just means that Glimcher is getting a higher value for the malls that are to be sold this year, which increases the dilution from lost NOI,» says Richard Moore, a REIT analyst with RBC
Capital Markets.